α-Tocopheryl quinone relieves HFCC-induced NASH via regulating oxidative stress, GLP-1 expression, intestinal flora imbalance, and the metabolism of glucose and lipids. Here, GLP1R is linked to metabolic dysfunction-associated steatohepatitis.